Semisynthesis of cytochrome c analogues: the effect of modifying the conserved residues 38 and 39PROUDFOOT, A. E. I; WALLACE, C. J. A.Biochemical journal (London. 1906). 1987, Vol 248, Num 3, pp 965-967, issn 0006-2936Article

On the relationship between oxidation-reduction potential and biological activity in cytochrome c analogues: results from four novel two-fragment complexesWALLACE, C. J. A; PROUDFOOT, A. E. I.Biochemical journal (London. 1906). 1987, Vol 245, Num 3, pp 773-779, issn 0006-2936Article

Conformation-directed recombination of enzyme-activated peptide fragments: a simple and efficient means to protein engineering. Its use in the creation of cytochrome c analogues for structure-function studiesPROUDFOOT, A. E. I; ROSE, K; WALLACE, C. J. A et al.The Journal of biological chemistry (Print). 1989, Vol 264, Num 15, pp 8764-8770, issn 0021-9258Article

Preparation and characterization of human interleukin-5 expressed in recombinant Escherichia coliPROUDFOOT, A. E. I; FATTAH, D; KAWASHIMA, E. H et al.Biochemical journal (London. 1906). 1990, Vol 270, Num 2, pp 357-361, issn 0006-2936, 5 p.Article

Enzyme-assisted semisynthesis of polypeptide active esters and their useROSE, K; HERRERO, C; PROUDFOOT, A. E. I et al.Biochemical journal (London. 1906). 1988, Vol 249, Num 1, pp 83-88, issn 0006-2936Article

Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonistSIMMONS, G; CLAPHAM, P. R; PICARD, L et al.Science (Washington, D.C.). 1997, Vol 276, Num 5310, pp 276-279, issn 0036-8075Article

A novel dimer configuration revealed by the crystal structure at 2.4 Å resolution of human interleukin-5MILBURN, M. V; HASSELL, A. M; LAMBERT, M. H et al.Nature (London). 1993, Vol 363, Num 6425, pp 172-176, issn 0028-0836Article

Substitutions engineered by chemical synthesis at three conserved sites in mitochondrial cytochrome c: thermodynamic and functional consequencesWALLACE, C. J. A; MASCAGNI, P; CHAIT, B. T et al.The Journal of biological chemistry (Print). 1989, Vol 264, Num 26, pp 15199-15209, issn 0021-9258, 11 p.Article

Crystallization and preliminary X-ray analysis of Candida albicans phosphomannose isomeraseTOLLEY, S; DAVIES, G; HUBBARD, R. E et al.Journal of molecular biology. 1994, Vol 237, Num 3, pp 349-350, issn 0022-2836Article

Purification cDNA cloning and heterologous expression of human phosphomannose isomerasePROUDFOOT, A. E. I; TURCATTI, G; WELLS, T. N. C et al.European journal of biochemistry (Print). 1994, Vol 219, Num 1-2, pp 415-423, issn 0014-2956Article

Recombinant human IL-6 expressed in E. coli undergoes selective N-terminal degradation : evidence that the protein consists of a stable core and a nonessential flexible N-terminalPROUDFOOT, A. E. I; BROWN, S. C; BERNARD, A. R et al.Journal of protein chemistry (Print). 1993, Vol 12, Num 4, pp 489-497, issn 0277-8033Article

Role of epithelial interleukin-8 (IL-8) and neutrophil IL-8 receptor A in Escherichia coli-induced transuroepithelial neutrophil migrationGODALY, G; PROUDFOOT, A. E. I; OFFORD, R. E et al.Infection and immunity. 1997, Vol 65, Num 8, pp 3451-3456, issn 0019-9567Article

Human interleukin-5 expressed in Escherichia coli has N-terminal modificationsROSE, K; REGAMEY, P.-O; ANDEREGG, R et al.Biochemical journal (London. 1984). 1992, Vol 286, pp 825-828, issn 0264-6021, 3Article

Monoclonal antibodies as probes of conformational changes in protein-engineered cytochrome cCOLLAWN, J. F; WALLACE, C. J. A; PROUDFOOT, A. E. I et al.The Journal of biological chemistry (Print). 1988, Vol 263, Num 18, pp 8625-8634, issn 0021-9258Article

Chemokine receptors-future therapeutic targets for HIV?PROUDFOOT, A. E. I; WELLS, T. N. C; CLAPHAM, P. R et al.Biochemical pharmacology. 1999, Vol 57, Num 5, pp 451-463, issn 0006-2952Article

The chemokine family. Potential therapeutic targets from allergy to HIV infectionPROUDFOOT, A. E. I.EJD. European journal of dermatology. 1998, Vol 8, Num 3, pp 147-157, issn 1167-1122Conference Paper

Multiple T cell antigenic determinants identified within a limited region of the horse cytochrome c moleculeBAUMHÜTER, S; WALLACE, C. J. A; PROUDFOOT, A. E. I et al.European journal of immunology. 1987, Vol 17, Num 5, pp 651-656, issn 0014-2980Article

Crystallization and preliminary X-ray diffraction studies of recombinant human interleukin-5HASSELL, A. M; WELLS, T. N. C; GRABER, P et al.Journal of molecular biology. 1993, Vol 229, Num 4, pp 1150-1152, issn 0022-2836Article

Phosphomannose isomerase from Saccharomyces cerevisiae contains two inhibitory metal ion binding sitesWELLS, T. N. C; COULIN, F; PAYTON, M. A et al.Biochemistry (Easton). 1993, Vol 32, Num 5, pp 1294-1301, issn 0006-2960Article

Modulation of antibody-mediated glomerular injury in vivo by interleukin-6KARKAR, A. M; TAM, F. W. K; PROUDFOOT, A. E. I et al.Kidney international. 1993, Vol 44, Num 5, pp 967-973, issn 0085-2538Conference Paper

Human interleukin-5 expressed in Escherichia coli : assignment of the disulfide bridges of the purified unglycosylated proteinPROUDFOOT, A. E. I; GWYNFOR DAVIES, J; TURCATTI, G et al.FEBS letters. 1991, Vol 283, Num 1, pp 61-64, issn 0014-5793, 4 p.Article

A new non-covalent complex of semisynthetically modified tryptic fragments of cytochrome cPROUDFOOT, A. E. I; WALLACE, C. A. J; HARRIS, D. E et al.Biochemical journal (London. 1906). 1986, Vol 239, Num 2, pp 333-337, issn 0006-2936Article

Treatment with Met-RANTES reduces lung injury in caerulein-induced pancreatitisBHATIA, M; PROUDFOOT, A. E. I; WELLS, T. N. C et al.British journal of surgery. 2003, Vol 90, Num 6, pp 698-704, issn 0007-1323, 7 p.Article

Coreceptor ligand inhibition of fetal brain cell infection by HIV type 1HIBBITTS, S; REEVES, J. D; SIMMONS, G et al.AIDS research and human retroviruses. 1999, Vol 15, Num 11, pp 989-1000, issn 0889-2229Article

Molecular cloning and characterisation of a neutrophil chemotactic protein from porcine plateletsPOWER, C. A; PROUDFOOT, A. E. I; MAGNENAT, E et al.European journal of biochemistry (Print). 1994, Vol 221, Num 2, pp 713-719, issn 0014-2956Article